Back to Agenda
Session 2 : Advancing Pharmacovigilance: regulatory use of database and Risk Management Plan
Session Chair(s)
Min-Jung Lim, MPHARM, RPH
CEO & Senior Pharmacovigilance Consultant, MediSafe, Pharmacovigilance Services, Korea, Republic of
In-sook Park, PHD
Former Director General, Korean Regulatory Science Center, Korea, Republic of
Speaker(s)
Takashi Waki, PHD, RPH
Epidemiologist, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Session 2 - 1
Bonggi Kim, PHD
Director, Korea Institute of Drug Safety and Risk Management, Korea, Republic of
Session 2 - 2
Jingyu (Julia) Luan, PHD
Executive Regulatory Science Director , AstraZeneca, United States
Session 2 - 3
Ju-Young Shin, PHD
Professor, Sungkyunkwan University, Korea, Republic of
Hyungjin Jung, MD, MBA
Senior Medical Director, Lundbeck Korea, Korea, Republic of
Younglim Kim, PHD
Director General, National Institute of Food & Drug Safety (NIFDS), Korea, Republic of
Nam-Kyong Choi, PHD
Research Professor, Division of Clinical Epidemiology, Seoul National University College of Medicine/Seoul National University Hospital, Korea, Republic of
Have an account?